Company intelligence / Profile preview

Pharos Capital Group

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Pharos Capital Group is a physician-founded private equity firm that invests $25–50 million in growing, primarily U.S.-based healthcare companies, especially value-based care and other services that lower costs, improve outcomes, and expand access in underserved communities.[3][4][7][12] It is an investor, not a drug or device developer, and therefore has no therapeutic pipeline or clinical-stage programs of its own.[1][3][12]

Industry: Investors

Partnerships

Hark Capital (NAV-based financing facilities)CoBank and USDA Rural Business Investment Company program collaboration for rural healthcare investments

Beyond the preview

Go deeper on Pharos Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharos Capital Group.

Explore the full profile